Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Moderator

Neil M. Bressler, MD

Professor of Ophthalmology
Johns Hopkins University
School of Medicine
Baltimore, Maryland

Disclosures

Participation by Dr Bressler does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Neil M. Bressler, MD, has the following relevant financial relationships:
Research funding from: Bayer HealthCare; Biogen; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche; Regeneron Pharmaceuticals, Inc.; Samsung Bioepis

Faculty

Peter K. Kaiser, MD

Chaney Family Endowed Chair for Ophthalmology Research
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cole Eye Institute
Cleveland, Ohio

Disclosures

Peter K. Kaiser, MD, has the following relevant financial relationships:
Consultant or advisor for: Alcon Laboratories, Inc.; Alexion Pharmaceuticals, Inc.; Allergan/AbbVie Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Biogen; Clearside Biomedical; Coherus; Genentech, Inc./Roche; IvericBio; Novartis Pharmaceuticals; Ocular Therapeutix; Oculis; Ocuphire; Regeneron Pharmaceuticals, Inc.; Regenxbio
Speaker or member of speakers bureau for: Allergan/AbbVie Inc.
Contracted researcher for: Apellis Pharmaceuticals
Stock options from: Ocular Therapeutix; Oculis; Ocuphire; RegenxBio

Jennifer I. Lim, MD

Professor of Ophthalmology
Marion H. Schenk Chair in Ophthalmology
Vice Chair, Director of Retina Service
University of Illinois at Chicago
Chicago, Illinois

Disclosures

Jennifer I. Lim, MD, has the following relevant financial relationships:
Consultant or advisor for: Alimera Sciences; Aura; Cognition; Eyenuk; Eyepoint; Genentech, Inc.; Luxa; Opthea; Quark Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Santen Pharmaceutical Co., Ltd.; Unity; Viridian
Research funding from: Adverum; Aldeyra Therapeutics, Inc.; Genentech Inc.; Janssen Pharmaceuticals; NGM Biopharmacueticals; Regeneron Pharmaceuticals, Inc.; Regenxbio; Spring Vision

Editors

Pakinam Aboulsaoud, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Yoji Yamaguchi, MA, ELS

Scientific Content Manager, Medscape, LLC

Disclosures

Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

What Biosimilars May Mean for the Future of Eye Care

Authors: Neil M. Bressler, MD; Peter K. Kaiser, MD; Jennifer I. Lim, MD
CME Released: 11/13/2023
Valid for credit through: 11/13/2024, 11:59 PM EST

Start Activity

Credits Available

Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

Optometry - This course is COPE approved for 0.50 hours of CE credit.

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for ophthalmologists and optometrists.

The goal of this activity is for learners to be better able to explain what biosimilars are and how they differ in the context of FDA approval of biosimilars in eye care.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Differences between innovator drugs and biosimilar drugs
- FDA requirements for biosimilars
- Safety of approved biosimilars

Disclosures

Moderator

Neil M. Bressler, MD

Professor of Ophthalmology
Johns Hopkins University
School of Medicine
Baltimore, Maryland

Disclosures

Participation by Dr Bressler does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.

Neil M. Bressler, MD, has the following relevant financial relationships:
Research funding from: Bayer HealthCare; Biogen; Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche; Regeneron Pharmaceuticals, Inc.; Samsung Bioepis

Faculty

Peter K. Kaiser, MD

Chaney Family Endowed Chair for Ophthalmology Research
Professor of Ophthalmology
Cleveland Clinic Lerner College of Medicine
Cole Eye Institute
Cleveland, Ohio

Disclosures

Peter K. Kaiser, MD, has the following relevant financial relationships:
Consultant or advisor for: Alcon Laboratories, Inc.; Alexion Pharmaceuticals, Inc.; Allergan/AbbVie Inc.; Bausch & Lomb Inc.; Bayer HealthCare; Biogen; Clearside Biomedical; Coherus; Genentech, Inc./Roche; IvericBio; Novartis Pharmaceuticals; Ocular Therapeutix; Oculis; Ocuphire; Regeneron Pharmaceuticals, Inc.; Regenxbio
Speaker or member of speakers bureau for: Allergan/AbbVie Inc.
Contracted researcher for: Apellis Pharmaceuticals
Stock options from: Ocular Therapeutix; Oculis; Ocuphire; RegenxBio

Jennifer I. Lim, MD

Professor of Ophthalmology
Marion H. Schenk Chair in Ophthalmology
Vice Chair, Director of Retina Service
University of Illinois at Chicago
Chicago, Illinois

Disclosures

Jennifer I. Lim, MD, has the following relevant financial relationships:
Consultant or advisor for: Alimera Sciences; Aura; Cognition; Eyenuk; Eyepoint; Genentech, Inc.; Luxa; Opthea; Quark Pharmaceuticals, Inc.; Regeneron Pharmaceuticals, Inc.; Santen Pharmaceutical Co., Ltd.; Unity; Viridian
Research funding from: Adverum; Aldeyra Therapeutics, Inc.; Genentech Inc.; Janssen Pharmaceuticals; NGM Biopharmacueticals; Regeneron Pharmaceuticals, Inc.; Regenxbio; Spring Vision

Editors

Pakinam Aboulsaoud, PharmD

Senior Medical Education Director, Medscape, LLC

Disclosures

Pakinam Aboulsaoud, PharmD, has no relevant financial relationships.

Yoji Yamaguchi, MA, ELS

Scientific Content Manager, Medscape, LLC

Disclosures

Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between the Postgraduate Institute for Medicine and Medscape.

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Contact This Provider

For Optometrists

In support of improving patient care, Postgraduate Institute for Medicine (PIM) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation: Postgraduate Institute for Medicine is accredited by COPE to provide continuing education to optometrists.

Credit Statement: This course is COPE approved for 0.5 hours of CE credit. Activity # 126674 and Course ID 86468-PH. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.

Contact this provider: www.pimed.com

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

Optometrists

In order to obtain your COPE certificate, please follow the steps below at the conclusion of the activity:

Go to www.cmeuniversity.com
Login or Create a New Account (will take less than 1 minute)
- If you receive a message when creating a new account that “the email you entered is already in use”, please click the Forgot my Username or Password link to have your Username and Password sent to you via email
- After logging in, you may be asked to verify/update your information; after doing so, click Save at the bottom of the page
Type in 18125 at the top of the page, “Find Post-Test/Evaluation by Course”, and click enter
Click on the activity title when it appears
Choose the type of credit you desire
Complete the online assessment
Receive an immediate CME/CE Certificate to download and/or print for your files

If you have questions regarding the certification of this activity, please contact PIM via email at [email protected].

processing....

Learning Feedback Questions

Clinician Handout

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

Page 1 of 2

CME Information Download Slides

Activity Transcript

PDF Downloads

Clinician Handout

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Moderator

Neil M. Bressler, MD

Faculty

Peter K. Kaiser, MD

Jennifer I. Lim, MD

Editors

Pakinam Aboulsaoud, PharmD

Yoji Yamaguchi, MA, ELS

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

CME

What Biosimilars May Mean for the Future of Eye Care

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Moderator

Neil M. Bressler, MD

Faculty

Peter K. Kaiser, MD

Jennifer I. Lim, MD

Editors

Pakinam Aboulsaoud, PharmD

Yoji Yamaguchi, MA, ELS

Compliance Reviewer

Stephanie Corder, ND, RN, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Optometrists

Instructions for Participation and Credit

Optometrists

What Biosimilars May Mean for the Future of Eye Care

Learning Feedback Questions

Clinician Handout

PDF Downloads